Navigation Links
Anesiva Announces First Quarter 2008 Financial Results
Date:5/8/2008

agreement signed earlier this year with Sigma-Tau; the agreement now

covers all major European markets except the British Isles and the

countries of Scandinavia. Discussions are underway to license Zingo in

those and in other major markets. Anesiva also signed an exclusive

marketing and distribution agreements with Green Vision Company for

major markets in the Middle East.

-- Publications in peer-reviewed journals on Zingo clinical trials, and

critical findings presented at medical meetings from market research

associated with the importance of treating IV pain, continue to

reinforce the need for a fast onset-of-action topical local anesthetic.

A recent survey of more than 2,000 pediatric nurses showed that nearly

all agree that inserting an IV line into a fearful, anxious child can

be challenging -- a situation that is encountered 76% of the time. The

nurses indicated that, although topical local anesthetics (TLAs) would

be beneficial in this setting, they are used less than a third of the

time. Barriers to use include slow onset of action (20 minutes or more)

and treatment delays, among others. Nearly all survey participants

(92%) agreed that patients would benefit from the use of a fast-acting

TLA for peripheral venous access procedures. The results of the survey,

which was sponsored by Anesiva, will be presented tomorrow at the

annual meeting of the American Pain Society.

Adlea

-- The Phase 3 clinical development program was initiated with two pivotal

trials evaluating Adlea in patients undergoing total knee replacement

surgery and in patients undergoing bunionectomy surgery. These two

pivotal trials, along with supporting Phase 2 trials in other surgical

settings, are intended to support a broad product label for Adlea for


'/>"/>

SOURCE Anesiva, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Anesiva Receives FDA Approval for Zingo(TM), a New, Innovative Product to Reduce Pain Associated with Needle Insertion Procedures in Children
2. Anesiva to Host Conference Call and Webcast Tomorrow to Discuss Encouraging Development in Zingo(TM) Program
3. Anesiva Grants Specific-Use License of Its Needle-Free Drug Delivery Technology to Particle Therapeutics for Diabetes Drug
4. Anesiva to Present at BioCenturys NewsMakers in the Biotech Industry Conference on September 6, 2007
5. Anesiva Signs Co-Promotion and Distribution Agreement With Sagent Pharmaceuticals for Zingo(TM) in U.S. Hospitals
6. Anesiva Outlines Comprehensive Commercialization Plan for FDA Approved Product Zingo(TM)
7. Anesiva Raises $45 Million in Common Stock Offering
8. Anesiva Announces Completion of Common Stock Offering
9. Anesiva Announces Fourth Quarter and Year End 2007 Financial Results Conference Call and February 2008 Conference Participation
10. Anesiva Appoints Daniel Janney to Board of Directors
11. Anesiva Announces Fourth Quarter and Year-End 2007 Financial Results and Provides 2008 Outlook
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... (PRWEB) January 22, 2015 Controlled Substance ... Alliance, which helps companies check the legal requirements around ... expand to China. , As their international operations ... globally adopting software solutions built as a result of ...
(Date:1/22/2015)... Nueva Jersey , 22 de enero de 2015  El ... abre hoy su llamada a nominaciones para 2015. Este ... ha hecho, o tiene el potencial para hacer, contribuciones ... nominaciones se aceptarán hasta el 15 de marzo de ...
(Date:1/22/2015)... GenoSpace , a precision medicine software company that has developed ... of genomic, imaging and other biomedical data in research and ... , CEO of Aspera, an IBM Company, to its board ... "We are pleased to welcome Michelle ...
(Date:12/24/2014)...  United Therapeutics Corporation (NASDAQ: UTHR ) announced ... has submitted a pre-market approval application to the U.S. ... Medtronic,s SynchroMed ® II implantable drug infusion system ... Therapeutics, Remodulin ® (treprostinil) Injection delivered intravenously to ...
Breaking Biology Technology:Global Compliance Service for Controlled Substances to Expand to China 2El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 2El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 3El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 4GenoSpace Expands Board with Appointment of Michelle Munson 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4
... Life Sciences,Holdings, Inc. (Nasdaq: ADLS ), a ... of novel drugs in the,therapeutic areas of infection, ... for the third quarter ended September 30,2008., ... available to common shareholders for the three months,ended ...
... (Nasdaq: PRXL ), a leading global biopharmaceutical ... the first to conduct a,Chinese bridging study outside ... bridging studies, which are conducted in early clinical ... gather,relevant ethnic data in the U.S., and save ...
... US In ... Locations Other Than Switzerland, BETHESDA, Md., Nov. 6 ... NWBT), today,announced that it has obtained US$1.65 million in funding ... Capital Group SPC,Ltd ("SDS") and a group of private investors ...
Cached Biology Technology:Advanced Life Sciences Announces Third Quarter 2008 Financial Results 2Advanced Life Sciences Announces Third Quarter 2008 Financial Results 3Advanced Life Sciences Announces Third Quarter 2008 Financial Results 4Advanced Life Sciences Announces Third Quarter 2008 Financial Results 5Advanced Life Sciences Announces Third Quarter 2008 Financial Results 6Advanced Life Sciences Announces Third Quarter 2008 Financial Results 7Advanced Life Sciences Announces Third Quarter 2008 Financial Results 8Advanced Life Sciences Announces Third Quarter 2008 Financial Results 9Advanced Life Sciences Announces Third Quarter 2008 Financial Results 10Advanced Life Sciences Announces Third Quarter 2008 Financial Results 11PAREXEL Expands Pioneering Asian Ethnobridging Expertise 2PAREXEL Expands Pioneering Asian Ethnobridging Expertise 3PAREXEL Expands Pioneering Asian Ethnobridging Expertise 4PAREXEL Expands Pioneering Asian Ethnobridging Expertise 5Northwest Secures US$1.65 Million Debt Financing 2Northwest Secures US$1.65 Million Debt Financing 3Northwest Secures US$1.65 Million Debt Financing 4
(Date:1/22/2015)... , Jan. 20, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... commerce market, reports on the recent success of the Wocket™ smart wallet ... Wocket smart wallet was named as one of the "11 Hot ... "5 Best Products Launched At CES So Far" by Newseveryday.com and "The ...
(Date:1/22/2015)... Jan. 22, 2015   EyeLock, Inc. , a market leader ... Steve Gerber to the new role of Senior ... for leading development of mobile platforms and wearable solutions for ... and innovation in the semiconductor industry to his role at ...
(Date:12/22/2014)... 22, 2014  The 2014 Holiday Season may be the ... Intelligence reports that the long anticipated floodgates for consumer ... demand for smart phones, tablets, and wearable mobile devices ... 2.5 billion users with nearly 4.8 billion biometric devices ...
Breaking Biology News(10 mins):CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 2CES Response for NXT-ID's Wocket Smart Wallet Kicks Off 2015 3EyeLock Names Steve Gerber as Senior Vice President of Mobile and Wearables 2First Season of Holiday Shopping with Mobile Biometric Payments Wraps Up With a Present for Biometrics Industry: A Rosy Forecast for More Than 2 Billion Users of 4.8 Billion Mobile Biometric Devices by 2020 2
... a calcium carbonate crystal, a simple mollusk may have evolved ... Speiser, a postdoctoral fellow in the Department of Ecology Evolution ... he collected in the Florida Keys. His research of their ... in a study published today by Current Biology . ...
... of couples struggling with infertility is on the rise, and ... fertilization (IVF), to get pregnant. Although IVF can be ... (i.e., twins or triplets), which are often caused by transferring ... to be born prematurely, and, as a result, many have ...
... DALLAS April 14, 2011 A natural hormone ... fibrosis, UT Southwestern Medical Center researchers have demonstrated. Scientists ... in mice that the anti-aging hormone Klotho suppressed both renal ... and the spread of cancer. The findings are available online ...
Cached Biology News:Eyes of rock let chitons see predators 2New study finds stronger regulations of in vitro fertilization may save lives 2Anti-aging hormone Klotho inhibits renal fibrosis, cancer growth 2
Anti-Wnt-2 Polyclonal Antibody Description: 100 g purified goat polyclonal antibody. Reacts with human/mouse/rat. Tested in Western blot/IP/IHC. Research Focus: signal transduction Storage...
...
Mynox is intended for research use only. Mynox is used for the elimination of Mycoplasma and Acholeplasma in cell and virus cultures, and other biologicals....
... Acridinium NHS ester can ... and nucleic acids. The covalently ... produce chemiluminescence in the presence ... ester-labeled proteins can be used ...
Biology Products: